Anew MedicalGRMLWPreferred / convertible

13F holders, Q3 2025 (September 30)
6holders −1
1new positions
2sold out
1famous investor
$0.10avg. 13F price*

At the end of Q3 2025, 6 institutions reported holding Anew Medical Inc. (GRMLW) in their 13F filings, down 1 from Q2 2025. 1 opened new positions and 2 sold out. The largest holders were Aristeia Capital, L.L.C. ($116K), D. E. Shaw & Co. ($30K) and Susquehanna International Group, LLP ($26K). One famous investor held it David E. Shaw ( of D. E. Shaw & Co.'s portfolio).

Company
Anew Medical Inc.
Filed as
KLOTHO NEUROSCIENCES INC (Q3 2025)
CUSIP
49876K111
Latest filing quarter
Q2 2026

History

Number of 13F holders

0510152025 Q3 2024: 22Q3 2024Q4 2024: 22Q4 2024Q1 2025: 19Q1 2025Q2 2025: 7Q2 2025Q3 2025: 6Q3 2025Q4 2025: 7Q4 2025Q1 2026: 5Q1 2026Q2 2026: 5Q2 2026

Total Exit/New Position Q2 2025 → Q3 2025

InstitutionsTotal Value
New Positions1$26K
Exits2$3K

All 13F filers, Q2 2025 → Q3 2025: 257,854 shares bought and 10,766 shares sold, net +247,088 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 6 holders

Aristeia Capital, L.L.C. — No change 1,106,754 $116K
D. E. Shaw & Co. — No change 300,000 $30K
Susquehanna International Group, LLP — New 257,854 $26K
Clear Street Group Inc. — — 54,202 $5K
OneDigital Investment Advisors LLC — No change 10,000 $950
Bank of America Corp. — No change 223 $21

"% of holder's portfolio" is GRMLW's weight in each manager's 13F, not the share of Anew Medical Inc. the manager owns.